REMLEAS is contraindicated in patients with a history of hypersensitivity to valbenazine or any components of REMLEAS. Rash, urticaria, and reactions consistent with angioedema (e.g., swelling of the face, lips, and mouth) have been reported [see Postmarketing Experience under Adverse Reactions].
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
